GAIN THERAPEUTICS INC

Gain Therapeutics Presents New Preclinical Data Demonstrating Potential Disease Modifying Benefits of its Novel Brain Penetrant Small Molecule Candidate GT-02287 in Two Preclinical Models of Parkinson’s Disease

19 9月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Gain Therapeutics to Present Data at Upcoming Medical Meetings

08 9月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Gain Therapeutics To Participate At The H.C. Wainwright 24th Annual Global Investment Conference

06 9月 2022 07:00:03 条件 Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Business Update

08 8月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the 2022 BTIG Biotechnology Conference

04 8月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the Jefferies Healthcare Conference

02 6月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the H.C. Wainwright Global Investment Conference

18 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports First Quarter 2022 Financial Results and Business Update

16 5月 2022 15:05:01 条件 Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive Preclinical Data On Its Gaucher Disease Program at IWGGD Symposium

11 5月 2022 08:30:00 条件 Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive Preclinical Data on its Small Molecule Lead Compound in GBA1 Parkinson’s Disease at XXVII IAPRD World Congress

06 5月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Gain Therapeutics to Participate in the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

26 4月 2022 16:18:58 条件 Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive Data on its Small Molecule Lead Compound in GBA1 Parkinson’s Disease at the 2022 Synuclein Meeting

12 4月 2022 12:00:00 条件 Nasdaq GlobeNewswire

Gain Therapeutics Presents Additional Confirmatory Data on its Gaucher Disease Program at the 2022 Glycolipid and Sphingolipid Biology Gordon Research Conference

29 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Full Year 2021 Financial Results and Business Update

24 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive Data on its Structurally Targeted Allosteric Regulators in both Parkinson’s and Alzheimer’s Disease at the AD/PD 2022 Conference

15 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Gain Therapeutics Announces Participation in Upcoming Investor and Scientific Conferences

01 3月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Gain Therapeutics Presents Preclinical Data on its Structurally Targeted Allosteric Regulators in GBA1 Gaucher Disease at the WORLDSymposium 2022

08 2月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Gain Therapeutics Outlines Key Objectives for 2022 Following its Inaugural R&D Day

04 2月 2022 11:06:54 条件 Nasdaq GlobeNewswire

Gain Therapeutics Announces Additional Details on its February 4th Virtual R&D Day

31 1月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Gain Therapeutics Announces R&D Day Event and Participation in Upcoming Conferences

18 1月 2022 07:00:02 条件 Nasdaq GlobeNewswire